JelenaKunovacMD

Chief Scientific Officer, IMA Group, Tarry Town, NY Founder; Altea Research,Las Vegas, Nevada; Alea Research, Phoenix, Arizona Co-Founder, President and CEO of Excell Research and Southern California Women Assistant Clinical Professor, UNLV, Las Vegas, Nevada

Join to view full profile

Dr. Kunovac is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kunovac's full profile

Already have an account?

Office
3012 W Charleston Blvd
Ste 100
Las Vegas, NV 89102
Phone+1 702-527-7401
Is this information wrong?

Education & Training

University of California (San Diego) Medical CenterResidency, Psychiatry, 1997 - 2001
University of Belgrade Faculty of MedicineClass of 1988

Certifications & Licensure

MT State Medical License 2015 - 2026
NV State Medical License 2010 - 2025
CO State Medical License 2020 - 2025
CA State Medical License 1998 - 2024
AZ State Medical License 2017 - 2024
WV State Medical License 2021 - 2024
VA State Medical License 2020 - 2024
IL State Medical License 2020 - 2023
American Board of Psychiatry and Neurology Psychiatry
Join now to see all

Clinical Trials

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression Start of enrollment: 2010 Nov 01
Completed
Phase 2
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01
Completed
Phase 3
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia Start of enrollment: 2011 Jul 01
Completed
Phase 3
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01
Completed
Phase 3
Major Depressive Disorder With Mixed Features Start of enrollment: 2012 Jan 01
Withdrawn
Phase 3
PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
Completed
Phase 3
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01
Completed
Phase 3
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients Start of enrollment: 2014 Apr 01
Completed
Phase 3
Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01
Completed
Phase 3
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
Emerging drugs for the treatment of major depressive disorder.
Jennifer Hong, Darian Vernon, Jelena Kunovac, Stephen Stahl> ;Expert Opinion on Emerging Drugs. 2022 Sep 1
9 citations
Efficacy and Safety of a 2-Month Formulation of Aripiprazole Lauroxil With 1-Day Initiation in Patients Hospitalized for Acute Schizophrenia Transitioned to Outpatient...
Peter J. Weiden, Amy Claxton, Jelena Kunovac, David P. Walling, Yangchun Du, Baiyun Yao, Sergey Yagoda, Ilda Bidollari, Elizabeth Keane, Ethan Cash> ;The Journal of Clinical Psychiatry. 2020 May 19
30 citations
Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3...
Steven G. Potkin, Jelena Kunovac, Bernard L. Silverman, Adam Simmons, Ying Jiang, Lauren DiPetrillo, David McDonnell> ;The Journal of Clinical Psychiatry. 2020 Mar 3
7 citations
Psychometric evaluation of the Work Readiness Questionnaire in schizophrenia
Steven G. Potkin, Dragana Bugarski-Kirola, Chris J. Edgar, Sherif Soliman, Stephanie Le Scouiller, Jelena Kunovac, Eugenio Miguel Velasco, George Garibaldi> ;CNS Spectrums. 2016 Apr 1
Development of the readiness for work questionnaire in schizophrenia.
Potkin, S.,Bugarski-Kirola, D.,Edgar, C.,Le Scouiller, S.,Kunovac, J.,Velasco, E. M.,Berardo, C.,Garibaldi, G. M.> ;Value Health. 2013 May 23
424 citations
Psychosocial Disability During the Long-term Course of Unipolar Major Depressive Disorder
Lewis L. Judd, Hagop S. Akiskal, Pamela J. Zeller, Martin P. Paulus, Andrew C. Leon, Jack D. Maser, Jean Endicott, William Coryell, Jelena L. Kunovac, Timothy I. Muell...> ;Archives of General Psychiatry. 2000 Apr 1
447 citations
Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse
Lewis L. Judd, Hagop S. Akiskal, Jack D. Maser, Pamela J. Zeller, Jean Endicott, William Coryell, Martin P. Paulus, Jelena L. Kunovac, Andrew C. Leon, Timothy I. Muell...> ;Journal of Affective Disorders. 1998 Sep 1
545 citations
A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.
Lewis L. Judd, Hagop S. Akiskal, Jack D. Maser, Pamela J. Zeller, Jean Endicott, William Coryell, Martin P. Paulus, Jelena L. Kunovac, Andrew C. Leon, Timothy I. Muell...> ;Archives of General Psychiatry. 1998 Aug 1
2 citations
Clinical Characteristics and Management of Unipolar Depressive Disorders Comorbid with Neurological Disorders
Lewis L. Judd, Jelena L. Kunovac> ;Neuropsychobiology. 1998 Mar 1
158 citations
Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences.
P. Lensi, G.B. Cassano, G Correddu, S. Ravagli, Jelena L. Kunovac, Hagop S. Akiskal> ;The British Journal of Psychiatry. 1996 Jul 1
24 citations
Future directions in anxiolytic pharmacotherapy.
Jelena L. Kunovac, Stephen M. Stahl> ;The Psychiatric Clinics of North America. 1995 Dec 1
Women who marry men with alcohol-use disorders.
Schuckit, M. A., Smith, T. L., Eng, M. Y., Kunovac, J.> ;Alcohol Clin Exp Res. 2002 Sep
Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS).
Judd, L. L., Kessler, R. C., Paulus, M. P., Zeller, P. V., Wittchen, H. U., Kunovac, J. L.> ;Acta Psychiatr Scand Suppl. 1998
Join now to see all

Press Mentions

Alkermes Presents New Psychiatry Data at Psych Congress 2020 Virtual ExperienceSeptember 14th, 2020
Long-Acting Aristada, Invega Sustenna Comparable for SchizophreniaApril 10th, 2019
Alkermes Says Long-Acting Drugs Could Help Schizophrenics Stay on Medication LongerApril 9th, 2019